vers la météo de la validation par utilisateur

Ingenuity075


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 65 - PMID ?

Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
                                      +---------------------COMP:V_PASS-N(in)---------------------+          
                                      |                +--------COMP:N-N(of)-------+              |          
                                      |                |            +-MOD_ATT:N-ADJ+              |          
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+            |       +MOD_AT+              |          
          |                           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,cholangiocarcinoma)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 1
                          +---------------------SUBJ:V-N--------------------+-----COMP:V-N(in)----+          
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+COMP:N-N(of)+       +OBJ:V-+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cholangiocarcinoma)

Analyse 2
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      |                +--------COMP:N-N(of)-------+              |          
                                      |                |            +-MOD_ATT:N-ADJ+              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            |       +MOD_AT+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
COMP:V-N(in) (associate,cholangiocarcinoma)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 3
                          +---------------------SUBJ:V-N--------------------+                                
                          +---------------COMP:N-N(of)--------------+       +-----COMP:V-N(in)----+          
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+            |       +OBJ:V-+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,upregulation)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cholangiocarcinoma)

Analyse 4
                                                       +--------COMP:N-N(of)-------+                         
                                                       |            +-MOD_ATT:N-ADJ+                         
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+            |       +MOD_AT+-COMP:N-N(in)-+          
          |                           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 5
                                                       +--------COMP:N-N(of)-------+                         
                                                       |            +-MOD_ATT:N-ADJ+                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            |       +MOD_AT+-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 6
                                                       +---------------COMP:N-N(in)---------------+          
                                                       +--------COMP:N-N(of)-------+              |          
                                                       |            +-MOD_ATT:N-ADJ+              |          
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+            |       +MOD_AT+              |          
          |                           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,mRNA)
COMP:N-N(in) (upregulation,cholangiocarcinoma)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 7
                                                       +--------COMP:N-N(of)-------+                         
                                                       |            +-MOD_ATT:N-ADJ+                         
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+            |       +MOD_AT+                         
          |                           |                |            |       |      |                         
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 8
                          +---------------------SUBJ:V-N--------------------+                                
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+COMP:N-N(of)+       +OBJ:V-+-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 9
                                                       +---------------COMP:N-N(in)---------------+          
                                                       +--------COMP:N-N(of)-------+              |          
                                                       |            +-MOD_ATT:N-ADJ+              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            |       +MOD_AT+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,mRNA)
COMP:N-N(in) (upregulation,cholangiocarcinoma)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 10
                                                       +--------COMP:N-N(of)-------+                         
                                                       |            +-MOD_ATT:N-ADJ+                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            |       +MOD_AT+                         
          |               |           |                |            |       |      |                         
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 11
                          +---------------------SUBJ:V-N--------------------+                                
                          +-------COMP:N-N(with)-------+                    +-----COMP:V-N(in)----+          
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                +COMP:N-N(of)+       +OBJ:V-+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,upregulation)
SUBJ:V_PASS-N (associate,human)
COMP:N-N(of) (upregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cholangiocarcinoma)

Analyse 12
                          +---------------------SUBJ:V-N--------------------+                                
                          +---------------COMP:N-N(of)--------------+       |                                
          +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+            |       +OBJ:V-+-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
COMP:V_PASS-N(with) (associate,upregulation)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 13
                                                       +--------COMP:N-N(of)-------+                         
                               +--------SUBJ:V-N-------+            +-MOD_ATT:N-ADJ+                         
                               |      +--MOD_ATT:N-ADJ-+            |       +MOD_AT+                         
                               |      |                |            |       |      |                         
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V-N (be,upregulation)
MOD_ATT:N-ADJ (upregulation,associate)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 14
                          +---------------------SUBJ:V-N--------------------+                                
                          +---------------COMP:N-N(of)--------------+       |                                
                          +-------COMP:N-N(with)-------+            |       +-----COMP:V-N(in)----+          
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                |            |       +OBJ:V-+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,upregulation)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cholangiocarcinoma)

Analyse 15
                                                       +--------COMP:N-N(of)-------+                         
                               +--------SUBJ:V-N-------+            +-MOD_ATT:N-ADJ+                         
                               |      +--MOD_ATT:N-ADJ-+            |       +MOD_AT+-COMP:N-N(in)-+          
                               |      |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V-N (be,upregulation)
MOD_ATT:N-ADJ (upregulation,associate)
COMP:N-N(of) (upregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 16
                                                       +---------------COMP:N-N(in)---------------+          
                                                       +--------COMP:N-N(of)-------+              |          
                               +--------SUBJ:V-N-------+            +-MOD_ATT:N-ADJ+              |          
                               |      +--MOD_ATT:N-ADJ-+            |       +MOD_AT+              |          
                               |      |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V-N (be,upregulation)
MOD_ATT:N-ADJ (upregulation,associate)
COMP:N-N(of) (upregulation,mRNA)
COMP:N-N(in) (upregulation,cholangiocarcinoma)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 17
                                      +---------------------COMP:V_PASS-N(in)---------------------+          
                                      |       +---------------OBJ:V-N--------------+              |          
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+COMP:N-N(of)+       +MOD_AT+              |          
          |                           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 18
                          +---------------------SUBJ:V-N--------------------+                                
                          +-------COMP:N-N(with)-------+                    |                                
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                +COMP:N-N(of)+       +OBJ:V-+-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,upregulation)
SUBJ:V_PASS-N (associate,human)
COMP:N-N(of) (upregulation,__SP__)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 19
                                      +---------------------COMP:V_PASS-N(in)---------------------+          
                                      |       +---------------OBJ:V-N--------------+              |          
                                      |       |        +----COMP:N-N(of)----+      |              |          
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+            +MOD_ATT+      |              |          
          |                           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 20
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      |       +---------------OBJ:V-N--------------+              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+       +MOD_AT+              |          
          |               |           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
COMP:V-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 21
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      |       +---------------OBJ:V-N--------------+              |          
                                      |       |        +----COMP:N-N(of)----+      |              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            +MOD_ATT+      |              |          
          |               |           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
COMP:V-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 22
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      +-------------------OBJ:V-N------------------+              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+       +MOD_AT+              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,cholangiocarcinoma)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 23
                          +---------------------SUBJ:V-N--------------------+                                
                          +---------------COMP:N-N(of)--------------+       |                                
                          +-------COMP:N-N(with)-------+            |       |                                
          +--MOD_ATT:N-N--+SUBJ:V_PASS+                |            |       +OBJ:V-+-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
COMP:N-N(with) (human,upregulation)
COMP:N-N(of) (human,__SP__)
SUBJ:V_PASS-N (associate,human)
SUBJ:V-N (__NODE__,human)
OBJ:V-N (__NODE__,mRNA)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 24
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      +-------------------OBJ:V-N------------------+              |          
                                      |                +----COMP:N-N(of)----+      |              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            +MOD_ATT+      |              |          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,cholangiocarcinoma)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)

Analyse 25
                                              +---------------OBJ:V-N--------------+                         
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+COMP:N-N(of)+       +MOD_AT+-COMP:N-N(in)-+          
          |                           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 26
                                              +---------------OBJ:V-N--------------+                         
                                              |        +----COMP:N-N(of)----+      |                         
          +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+            +MOD_ATT+      +-COMP:N-N(in)-+          
          |                           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
SUBJ:V_PASS-N (associate,Cholangiocarcinoma)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 27
                                              +---------------OBJ:V-N--------------+                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+       +MOD_AT+-COMP:N-N(in)-+          
          |               |           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 28
                                              +---------------OBJ:V-N--------------+                         
                                              |        +----COMP:N-N(of)----+      |                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            +MOD_ATT+      +-COMP:N-N(in)-+          
          |               |           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 29
                                      +-------------------OBJ:V-N------------------+                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+       +MOD_AT+-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 30
                                      +-------------------OBJ:V-N------------------+                         
                                      |                +----COMP:N-N(of)----+      |                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+            +MOD_ATT+      +-COMP:N-N(in)-+          
          |               |           |                |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 31
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      +-------------------OBJ:V-N------------------+              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+              |              |          
          |               |           |                |            |              |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,cholangiocarcinoma)
COMP:N-N(of) (upregulation,__SP__)

Analyse 32
                                      +-------------------OBJ:V-N------------------+                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+              +-COMP:N-N(in)-+          
          |               |           |                |            |              |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:N-N(of) (upregulation,__SP__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)

Analyse 33
                                      +------------------------COMP:V-N(in)-----------------------+          
                                      +-------------------OBJ:V-N------------------+              |          
                                      |       +-----------OBJ:V-N-----------+      |              |          
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+       |      |              |          
          |               |           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
COMP:V-N(in) (associate,cholangiocarcinoma)
OBJ:V-N (with,__NODE__)
COMP:N-N(of) (upregulation,__SP__)

Analyse 34
                                      +-------------------OBJ:V-N------------------+                         
                                      |       +-----------OBJ:V-N-----------+      |                         
          +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+       |      +-COMP:N-N(in)-+          
          |               |           |       |        |            |       |      |              |          
 Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma .
MOD_ATT:N-N (human,Cholangiocarcinoma)
SUBJ:V-N (associate,human)
COMP:V-N(with) (associate,upregulation)
OBJ:V-N (associate,mRNA)
OBJ:V-N (with,__NODE__)
COMP:N-N(of) (upregulation,__SP__)
COMP:N-N(in) (mRNA,cholangiocarcinoma)